News

Parnax Lab Ltd share price inched up 1.56% to Rs 133.05. The Company`s net profit tumbled by 80.28% to Rs 0.43 crore, while revenue from operations reduced 18.43% to Rs 56.8 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, rising 4.63%. It has marginally improved by 0.66% over last one week and advanced by 11.20% in last one month while the market capitalization of Parnax Lab Ltd has slipped by 0.97% and 17.74% in the same period respectively. Profit before tax (PBT) of Parnax Lab Ltd stood at Rs 0.6 crore in Q2 FY26, tanking 86.55% year-on-year, and crashing by 80.00% quarter-on-quarter. EBITDA came in at Rs 4 crore, nosediving by 42.76% YoY and expanding by 43.10% sequentially. Total expenses reduced by 18.06% to Rs 54.72 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 33.44 crore, tumbling by 23.58% YoY, while employee benefits expense was at Rs 7.82 crore, rising by 8.61% YoY. For the TTM ended FY26, revenue from operations declined slightly by 0.51% to Rs 187.74 crore, while net profit rose by 19.96% to Rs 11.54 crore, compared to previous TTM. EBITDA jumped by 2214% to Rs 25.09 crore, and PBT jumped 30.04% to Rs 15.67 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 32.3 crore in FY26, as against Rs 15.88 crore in FY25. Parnax Lab Ltd ticked higher by 2.35% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.

Parnax Lab will hold a meeting of the Board of Directors of the Company on 14 August 2026.

Net profit of Parnax Lab declined 25.34% to Rs 2.18 crore in the quarter ended March 2026 as against Rs 2.92 crore during the previous quarter ended March 2025. Sales rose 41.99% to Rs 69.63 crore in the quarter ended March 2026 as against Rs 49.04 crore during the previous quarter ended March 2025.For the full year,net profit rose 2.26% to Rs 11.78 crore in the year ended March 2026 as against Rs 11.52 crore during the previous year ended March 2025. Sales rose 32.39% to Rs 248.54 crore in the year ended March 2026 as against Rs 187.74 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales69.6349.04 42 248.54187.74 32 OPM %7.0213.52 -10.9614.25 - PBDT5.265.78 -9 25.3223.05 10 PBT3.233.95 -18 17.2815.67 10 NP2.182.92 -25 11.7811.52 2 Powered by Capital Market - Live News

Parnax Lab will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Net profit of Parnax Lab rose 123.97% to Rs 2.71 crore in the quarter ended December 2025 as against Rs 1.21 crore during the previous quarter ended December 2024. Sales rose 56.49% to Rs 62.94 crore in the quarter ended December 2025 as against Rs 40.22 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales62.9440.22 56 OPM %10.8810.62 - PBDT6.353.23 97 PBT4.391.45 203 NP2.711.21 124 Powered by Capital Market - Live News